Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1991 Apr 15;88(8):3069–3073. doi: 10.1073/pnas.88.8.3069

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.

M Blank 1, J Cohen 1, V Toder 1, Y Shoenfeld 1
PMCID: PMC51386  PMID: 2014226

Abstract

The primary anti-phospholipid syndrome is characterized by recurrent venous and arterial thromboembolic phenomena, recurrent fetal loss, thrombocytopenia, and serological evidence of anti-cardiolipin (aCL) antibodies or/and the presence of lupus anticoagulant (prolonged activated partial thromboplastin time). The exact role of aCL antibodies in pathogenesis is not clear and the mechanism by which the antibodies may induce the various manifestations is unknown. In the current study we evaluated the effect of passive transfer of aCL antibodies (to the tail vein of naive mice) on fecundity, fetal loss (fetal resorption), and the weight of embryos and placentae. Two types of aCL antibodies were employed: (i) mouse monoclonal aCL antibodies derived from a BALB/c mouse in which experimental systemic lupus erythematosus was induced by a pathogenic idiotype (idiotype 16/6) of anti-DNA antibodies and (ii) polyclonal IgG and IgM aCL antibodies derived from serum of a patient with primary anti-phospholipid syndrome. After infusion of either antibody (10 micrograms per mouse) we could demonstrate lower fecundity rate, increased resorption index of embryos (equivalent to recurrent fetal loss), lower number of embryos per pregnancy, and lower mean weights of embryos and placentae in comparison to mice infused with appropriate control immunoglobulins. We conclude that the aCL antibodies may have direct effects on fecundity and on the outcome of pregnancy.

Full text

PDF
3069

Images in this article

3071Image
on p.3071
3071Image
on p.3071
3072Image
on p.3072

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALARCON SEGOVIA D., OSMUNDSON P. J. PERIPHERAL VASCULAR SYNDROMES ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Ann Intern Med. 1965 May;62:907–919. doi: 10.7326/0003-4819-62-5-907. [DOI] [PubMed] [Google Scholar]
  2. Alarcón-Segovia D. Pathogenesis of systemic lupus erythematosus. Possible participation of antiphospholipid antibodies. Isr J Med Sci. 1989 Dec;25(12):669–674. [PubMed] [Google Scholar]
  3. Alarcón-Segovia D., Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol. 1989 Apr;16(4):482–488. [PubMed] [Google Scholar]
  4. Asherson R. A., Khamashta M. A., Ordi-Ros J., Derksen R. H., Machin S. J., Barquinero J., Outt H. H., Harris E. N., Vilardell-Torres M., Hughes G. R. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989 Nov;68(6):366–374. [PubMed] [Google Scholar]
  5. BOWIE E. J., THOMPSON J. H., Jr, PASCUZZI C. A., OWEN C. A., Jr THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS. J Lab Clin Med. 1963 Sep;62:416–430. [PubMed] [Google Scholar]
  6. Berger P., Kofler R., Wick G. Monoclonal antibodies against human chorionic gonadotropin (hCG): II. Affinity and ability to neutralize the biological activity of hCG. Am J Reprod Immunol. 1984 Jun;5(4):157–160. doi: 10.1111/j.1600-0897.1984.tb00188.x. [DOI] [PubMed] [Google Scholar]
  7. Canoso R. T., Sise H. S. Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities. Am J Hematol. 1982 Sep;13(2):121–129. doi: 10.1002/ajh.2830130204. [DOI] [PubMed] [Google Scholar]
  8. Cohen A. J., Philips T. M., Kessler C. M. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Feb;104(2):175–180. doi: 10.7326/0003-4819-104-2-175. [DOI] [PubMed] [Google Scholar]
  9. Deleze M., Alarcón-Segovia D., Valdes-Macho E., Oria C. V., Ponce de Leon S. Relationship between antiphospholipid antibodies and recurrent fetal loss in patients with systemic lupus erythematosus and apparently healthy women. J Rheumatol. 1989 Jun;16(6):768–772. [PubMed] [Google Scholar]
  10. Dührsen U., Paar D., Kölbel C., Boekstegers A., Metz-Kurschel U., Wagner R., Kirch W., Meusers P., König E., Brittinger G. Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations. Klin Wochenschr. 1987 Sep 15;65(18):852–859. doi: 10.1007/BF01737004. [DOI] [PubMed] [Google Scholar]
  11. Elias M., Eldor A. Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. Arch Intern Med. 1984 Mar;144(3):510–515. [PubMed] [Google Scholar]
  12. Gastineau D. A., Kazmier F. J., Nichols W. L., Bowie E. J. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol. 1985 Jul;19(3):265–275. doi: 10.1002/ajh.2830190308. [DOI] [PubMed] [Google Scholar]
  13. Gleicher N., el-Roeiy A., Confino E., Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol. 1989 Jun;160(6):1376–1385. doi: 10.1016/0002-9378(89)90858-2. [DOI] [PubMed] [Google Scholar]
  14. Glueck H. I., Kant K. S., Weiss M. A., Pollak V. E., Miller M. A., Coots M. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med. 1985 Aug;145(8):1389–1395. [PubMed] [Google Scholar]
  15. Harris E. N. A reassessment of the antiphospholipid syndrome. J Rheumatol. 1990 Jun;17(6):733–735. [PubMed] [Google Scholar]
  16. Harris E. N., Gharavi A. E., Hegde U., Derue G., Morgan S. H., Englert H., Chan J. K., Asherson R. A., Hughes G. R. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol. 1985 Feb;59(2):231–234. doi: 10.1111/j.1365-2141.1985.tb02989.x. [DOI] [PubMed] [Google Scholar]
  17. Jungers P., Liote F., Dautzenberg M. D., Gazengel C., Dougados M., Tron F., Bach J. F. Lupus anticoagulant and thrombosis in systemic lupus erythematosus. Lancet. 1984 Mar 10;1(8376):574–575. doi: 10.1016/s0140-6736(84)90982-6. [DOI] [PubMed] [Google Scholar]
  18. Keane A., Woods R., Dowding V., Roden D., Barry C. Anticardiolipin antibodies in rheumatoid arthritis. Br J Rheumatol. 1987 Oct;26(5):346–350. doi: 10.1093/rheumatology/26.5.346. [DOI] [PubMed] [Google Scholar]
  19. Khamashta M. A., Harris E. N., Gharavi A. E., Derue G., Gil A., Vázquez J. J., Hughes G. R. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis. 1988 Oct;47(10):849–854. doi: 10.1136/ard.47.10.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kozlowski C. L., Johnson M. J., Gorst D. W., Willey R. F. Lung cancer, immune thrombocytopenia and the lupus inhibitor. Postgrad Med J. 1987 Sep;63(743):793–795. doi: 10.1136/pgmj.63.743.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lechner K., Pabinger-Fasching I. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis. 1985;15(4):254–262. doi: 10.1159/000215157. [DOI] [PubMed] [Google Scholar]
  22. Mackworth-Young C. G., Loizou S., Walport M. J. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis. 1989 May;48(5):362–367. doi: 10.1136/ard.48.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mendlovic S., Brocke S., Shoenfeld Y., Ben-Bassat M., Meshorer A., Bakimer R., Mozes E. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2260–2264. doi: 10.1073/pnas.85.7.2260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ordi J., Barquinero J., Vilardell M., Jordana R., Tolosa C., Selva A., Genover E. Fetal loss treatment in patients with antiphospholipid antibodies. Ann Rheum Dis. 1989 Oct;48(10):798–802. doi: 10.1136/ard.48.10.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sanfelippo M. J., Drayna C. J. Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis. Am J Clin Pathol. 1982 Mar;77(3):275–279. doi: 10.1093/ajcp/77.3.275. [DOI] [PubMed] [Google Scholar]
  26. Seibold J. R., Knight P. J., Peter J. B. Anticardiolipin antibodies in systemic sclerosis. Arthritis Rheum. 1986 Aug;29(8):1052–1053. doi: 10.1002/art.1780290819. [DOI] [PubMed] [Google Scholar]
  27. Smorodinsky N. I., Ghendler Y., Bakimer R., Chaitchuk S., Keydar I., Shoenfeld Y. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies. Eur J Immunol. 1988 Nov;18(11):1713–1718. doi: 10.1002/eji.1830181109. [DOI] [PubMed] [Google Scholar]
  28. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  29. Triplett D. A., Harris E. N. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol. 1989 Nov-Dec;21(3-4):123–131. doi: 10.1111/j.1600-0897.1989.tb01016.x. [DOI] [PubMed] [Google Scholar]
  30. Vaarala O., Palosuo T., Kleemola M., Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol. 1986 Oct;41(1):8–15. doi: 10.1016/0090-1229(86)90046-2. [DOI] [PubMed] [Google Scholar]
  31. Walport M. J. Pregnancy and antibodies to phospholipids. Ann Rheum Dis. 1989 Oct;48(10):795–797. doi: 10.1136/ard.48.10.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wintzen A. R., Broekmans A. W., Bertina R. M., Briët E., Briët P. E., Zecha A., Vielvoye G. J., Bots G. T. Cerebral haemorrhagic infarction in young patients with hereditary protein C deficiency: evidence for "spontaneous" cerebral venous thrombosis. Br Med J (Clin Res Ed) 1985 Feb 2;290(6465):350–352. doi: 10.1136/bmj.290.6465.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zarrabi M. H., Zucker S., Miller F., Derman R. M., Romano G. S., Hartnett J. A., Varma A. O. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med. 1979 Aug;91(2):194–199. doi: 10.7326/0003-4819-91-2-194. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES